BMJ OPEN RESPIR RES 润色咨询

BMJ Open Respiratory Research

出版年份：暂无数据 年文章数：513 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2174200, encodeId=c61f21e4200e6, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：Copd;呼吸<br>经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b945427479, createdName=ms3000000140014381, createdTime=Mon Dec 11 09:22:52 CST 2023, time=2023-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238853, encodeId=7ead12388534a, content=偏重的研究方向：呼吸系统疾病;膀胱癌<br>经验分享：2022/08/15上午提交稿件<br>2022/08/15下午2点编辑返回，要求修改格式<br>2022/08/15下午6点就显示in peer review<br>不知道是不是真的送外审了，继续更新吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/09cc2ef1a3ce4358b3a0b674a1148d18/0249c77562784ebb9c835e8c16aef5aa.jpg, createdBy=44ed5456069, createdName=ElSolAzul, createdTime=Mon Aug 15 18:24:26 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233241, encodeId=d155123324187, content=好像还没人，先记录一下投稿过程吧在这：<br>2022/7/17: 投稿<br>2022/7/18: 编辑返回，要求修改；修改后重新提交<br>2022/7/18: 重新提交后当天In Peer Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220615/578dba9b787c425badc007604abaa5db/9fb1b073f8a243c9bd6e15325269f925.jpg, createdBy=15245410727, createdName=年年有余的余, createdTime=Mon Jul 18 18:25:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113953, encodeId=4ed6111395384, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113954, encodeId=8ed211139544a, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-12-11 ms3000000140014381

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向：Copd;呼吸
    经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2174200, encodeId=c61f21e4200e6, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：Copd;呼吸<br>经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b945427479, createdName=ms3000000140014381, createdTime=Mon Dec 11 09:22:52 CST 2023, time=2023-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238853, encodeId=7ead12388534a, content=偏重的研究方向：呼吸系统疾病;膀胱癌<br>经验分享：2022/08/15上午提交稿件<br>2022/08/15下午2点编辑返回，要求修改格式<br>2022/08/15下午6点就显示in peer review<br>不知道是不是真的送外审了，继续更新吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/09cc2ef1a3ce4358b3a0b674a1148d18/0249c77562784ebb9c835e8c16aef5aa.jpg, createdBy=44ed5456069, createdName=ElSolAzul, createdTime=Mon Aug 15 18:24:26 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233241, encodeId=d155123324187, content=好像还没人，先记录一下投稿过程吧在这：<br>2022/7/17: 投稿<br>2022/7/18: 编辑返回，要求修改；修改后重新提交<br>2022/7/18: 重新提交后当天In Peer Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220615/578dba9b787c425badc007604abaa5db/9fb1b073f8a243c9bd6e15325269f925.jpg, createdBy=15245410727, createdName=年年有余的余, createdTime=Mon Jul 18 18:25:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113953, encodeId=4ed6111395384, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113954, encodeId=8ed211139544a, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-08-15 ElSolAzul

    偏重的研究方向：呼吸系统疾病;膀胱癌
    经验分享：2022/08/15上午提交稿件
    2022/08/15下午2点编辑返回，要求修改格式
    2022/08/15下午6点就显示in peer review
    不知道是不是真的送外审了，继续更新吧

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2174200, encodeId=c61f21e4200e6, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：Copd;呼吸<br>经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b945427479, createdName=ms3000000140014381, createdTime=Mon Dec 11 09:22:52 CST 2023, time=2023-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238853, encodeId=7ead12388534a, content=偏重的研究方向：呼吸系统疾病;膀胱癌<br>经验分享：2022/08/15上午提交稿件<br>2022/08/15下午2点编辑返回，要求修改格式<br>2022/08/15下午6点就显示in peer review<br>不知道是不是真的送外审了，继续更新吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/09cc2ef1a3ce4358b3a0b674a1148d18/0249c77562784ebb9c835e8c16aef5aa.jpg, createdBy=44ed5456069, createdName=ElSolAzul, createdTime=Mon Aug 15 18:24:26 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233241, encodeId=d155123324187, content=好像还没人，先记录一下投稿过程吧在这：<br>2022/7/17: 投稿<br>2022/7/18: 编辑返回，要求修改；修改后重新提交<br>2022/7/18: 重新提交后当天In Peer Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220615/578dba9b787c425badc007604abaa5db/9fb1b073f8a243c9bd6e15325269f925.jpg, createdBy=15245410727, createdName=年年有余的余, createdTime=Mon Jul 18 18:25:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113953, encodeId=4ed6111395384, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113954, encodeId=8ed211139544a, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-07-18 年年有余的余

    好像还没人，先记录一下投稿过程吧在这：
    2022/7/17: 投稿
    2022/7/18: 编辑返回，要求修改；修改后重新提交
    2022/7/18: 重新提交后当天In Peer Review

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2174200, encodeId=c61f21e4200e6, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：Copd;呼吸<br>经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b945427479, createdName=ms3000000140014381, createdTime=Mon Dec 11 09:22:52 CST 2023, time=2023-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238853, encodeId=7ead12388534a, content=偏重的研究方向：呼吸系统疾病;膀胱癌<br>经验分享：2022/08/15上午提交稿件<br>2022/08/15下午2点编辑返回，要求修改格式<br>2022/08/15下午6点就显示in peer review<br>不知道是不是真的送外审了，继续更新吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/09cc2ef1a3ce4358b3a0b674a1148d18/0249c77562784ebb9c835e8c16aef5aa.jpg, createdBy=44ed5456069, createdName=ElSolAzul, createdTime=Mon Aug 15 18:24:26 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233241, encodeId=d155123324187, content=好像还没人，先记录一下投稿过程吧在这：<br>2022/7/17: 投稿<br>2022/7/18: 编辑返回，要求修改；修改后重新提交<br>2022/7/18: 重新提交后当天In Peer Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220615/578dba9b787c425badc007604abaa5db/9fb1b073f8a243c9bd6e15325269f925.jpg, createdBy=15245410727, createdName=年年有余的余, createdTime=Mon Jul 18 18:25:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113953, encodeId=4ed6111395384, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113954, encodeId=8ed211139544a, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    讨论中一般可以讨论什么？

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2174200, encodeId=c61f21e4200e6, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向：Copd;呼吸<br>经验分享：2023–5月投，12月二审，临床评审非常nice,统计是，评审非常专业，非常细致，第一次12个问题，9个全统计，第二次三个不同的统计问题，附件里面的包括学历年限需要标注，还有一些公共问题，我把北爱儿兰当作英国的，被告知是独立国家。但愿一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b945427479, createdName=ms3000000140014381, createdTime=Mon Dec 11 09:22:52 CST 2023, time=2023-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238853, encodeId=7ead12388534a, content=偏重的研究方向：呼吸系统疾病;膀胱癌<br>经验分享：2022/08/15上午提交稿件<br>2022/08/15下午2点编辑返回，要求修改格式<br>2022/08/15下午6点就显示in peer review<br>不知道是不是真的送外审了，继续更新吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/09cc2ef1a3ce4358b3a0b674a1148d18/0249c77562784ebb9c835e8c16aef5aa.jpg, createdBy=44ed5456069, createdName=ElSolAzul, createdTime=Mon Aug 15 18:24:26 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233241, encodeId=d155123324187, content=好像还没人，先记录一下投稿过程吧在这：<br>2022/7/17: 投稿<br>2022/7/18: 编辑返回，要求修改；修改后重新提交<br>2022/7/18: 重新提交后当天In Peer Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220615/578dba9b787c425badc007604abaa5db/9fb1b073f8a243c9bd6e15325269f925.jpg, createdBy=15245410727, createdName=年年有余的余, createdTime=Mon Jul 18 18:25:02 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113953, encodeId=4ed6111395384, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113954, encodeId=8ed211139544a, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=577, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 小动量

    讨论中我和之前发表文章结果不一致怎么处理？

    1

    展开1条回复
共15条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分